InsiderTrades

Form 4 for FHTX Foghorn Therapeutics Inc.

Accepted 2024-09-18 00:00:00 ET · period of report 2024-09-16 · accession 0001562180-24-006859 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2024-09-18 2024-09-16+ FHTX Costa Carlos CHRO M - OptEx $3.72 +10.7K 10.3K New +$39.7K
DMT 2024-09-18 2024-09-16+ FHTX Costa Carlos CHRO S - Sale+OE $10.04 -10.7K 0 -100% -$107.1K
DMT 2024-09-18 2024-09-16+ FHTX Costa Carlos CHRO M - OptEx $0.00 -10.7K 88.0K -11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-09-16 M A 400 $3.72 400 D — —
2 Common Common Stock 2024-09-17 M A 10,272 $3.72 10,272 D — —
3 Common Common Stock 2024-09-16 S D 400 $10.00 0 D — —
4 Common Common Stock 2024-09-17 S D 10,272 $10.04 0 D — — (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.18 per share.
5 Derivative Stock Option (right to buy) 2024-09-16 M D 400 $0.00 98,248 D $3.72 · — to 2029-02-12 400 Common Stock (F3) The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested.
6 Derivative Stock Option (right to buy) 2024-09-17 M D 10,272 $0.00 87,976 D $3.72 · — to 2029-02-12 10,272 Common Stock (F3) The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested.